Probleme bei der Darstellung von ARIVA.DE?

  • Laden unsere Charts bei Ihnen nicht?
  • Wird unser Forum bei Ihnen nicht korrekt dargestellt?

Sie nutzen einen Adblocker, der hierfür verantwortlich ist. Hierauf hat ARIVA.DE leider keinen Einfluss. Bitte heben Sie die Blockierung von ARIVA.DE in Ihrem Adblocker auf.

Probleme bei der Darstellung von ARIVA.DE?

Top-Thema

20:26 Uhr
Aktien New York: Erneut Bestmarken dank guter Unter­nehmens­zahlen

Luminex Corporation To Present At Cantor Fitzgerald's Global Healthcare Conference

Dienstag, 19.09.2017 22:10 von

PR Newswire

AUSTIN, Texas, Sept. 19, 2017 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's Global Healthcare Conference to be held September 25 -27, 2017, in New York, NY.

The investor presentation will begin at 10:20 a.m. Eastern time on Tuesday, September 26, 2017.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

ABOUT LUMINEX CORPORATION

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Contacts:

Harriss T. Currie


Sr. Vice President, Finance and CFO


512-219-8020


hcurrie@luminexcorp.com




Matt Scalo


Sr. Director, Investor Relations


512-219-8020


mscalo@luminexcorp.com

 

Luminex logo. (PRNewsFoto/LUMINEX CORP.)

 

View original content with multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-to-present-at-cantor-fitzgeralds-global-healthcare-conference-300522168.html

SOURCE Luminex Corporation